​
​

Akili (AKLI) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

AKLI Stock Forecast

Akili stock forecast is as follows: an average price target of $3.25 (represents a 652.31% upside from AKLI’s last price of $0.43) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

AKLI Price Target

The average price target for Akili (AKLI) is $3.25 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $4.50 to $2.00. This represents a potential 652.31% upside from AKLI's last price of $0.43.

AKLI Analyst Ratings

Buy

According to 2 Wall Street analysts, Akili's rating consensus is 'Buy'. The analyst rating breakdown for AKLI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Akili Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 28, 2022Morgan Stanley--94.82%362.96%
Nov 15, 2022Credit Suisse--155.68%941.67%
Row per page
Go to

The latest Akili stock forecast, released on Dec 28, 2022 by Morgan Stanley company, set a price target of $2.00, which represents a 94.82% increase from the stock price at the time of the forecast ($1.03), and a 362.96% increase from AKLI last price ($0.43).

Akili Price Target by Period

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.43$0.43$0.43
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Akili stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Akili's last price of $0.43. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 28, 2022Morgan StanleyEqual-WeightInitialise
Nov 15, 2022Credit SuisseOutperformOutperformHold
Row per page
Go to

Akili's last stock rating was published by Morgan Stanley on Dec 28, 2022. The company Initialise its AKLI rating from "null" to "Equal-Weight".

Akili Financial Forecast

Akili Revenue Forecast

Dec 26Oct 26Jul 26Mar 26Dec 25Oct 25Jul 25Mar 25Dec 24Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Dec 22
Revenue---------------$113.00K$111.00K
Avg Forecast$2.45M$2.24M$2.03M$1.82M$1.60M$1.50M$1.30M$1.20M$1.00M$1.00M$900.00K$800.00K$800.00K$323.00K$237.81K$191.17K$52.34K
High Forecast$2.45M$2.24M$2.03M$1.82M$1.60M$1.50M$1.30M$1.20M$1.00M$1.00M$900.00K$800.00K$800.00K$323.00K$237.81K$191.17K$52.34K
Low Forecast$2.45M$2.24M$2.03M$1.82M$1.60M$1.50M$1.30M$1.20M$1.00M$1.00M$900.00K$800.00K$800.00K$323.00K$237.81K$191.17K$52.34K
# Analysts11111111111111111
Surprise %---------------0.59%2.12%

Akili's average Quarter revenue forecast for Jul 23 based on 1 analysts is $237.81K, with a low forecast of $237.81K, and a high forecast of $237.81K. AKLI's average Quarter revenue forecast represents a 110.45% increase compared to the company's last Quarter revenue of $113.00K (Mar 23).

Akili EBITDA Forecast

Dec 26Oct 26Jul 26Mar 26Dec 25Oct 25Jul 25Mar 25Dec 24Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Dec 22
# Analysts11111111111111111
EBITDA---------------$-18.00M$-22.11M
Avg Forecast$-2.45M$-2.24M$-2.03M$-1.82M$-1.60M$-1.50M$-1.30M$-1.20M$-1.00M$-1.00M$-900.00K$-800.00K$-800.00K$-323.00K$-237.81K$-191.17K$-52.34K
High Forecast$-2.45M$-2.24M$-2.03M$-1.82M$-1.60M$-1.50M$-1.30M$-1.20M$-1.00M$-1.00M$-900.00K$-800.00K$-800.00K$-323.00K$-237.81K$-191.17K$-52.34K
Low Forecast$-2.45M$-2.24M$-2.03M$-1.82M$-1.60M$-1.50M$-1.30M$-1.20M$-1.00M$-1.00M$-900.00K$-800.00K$-800.00K$-323.00K$-237.81K$-191.17K$-52.34K
Surprise %---------------94.15%422.35%

undefined analysts predict AKLI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Akili's previous annual EBITDA (undefined) of $NaN.

Akili Net Income Forecast

Dec 26Oct 26Jul 26Mar 26Dec 25Oct 25Jul 25Mar 25Dec 24Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Dec 22
# Analysts11111111111111111
Net Income---------------$-22.93M$-16.82M
Avg Forecast$-10.21M$-10.21M$-10.21M$-9.42M$-9.42M$-9.42M$-9.42M$-9.42M$-10.21M$-10.21M$-10.21M$-10.99M$-16.49M$-17.01M$-15.91M$-16.94M$-19.75M
High Forecast$-10.21M$-10.21M$-10.21M$-9.42M$-9.42M$-9.42M$-9.42M$-9.42M$-10.21M$-10.21M$-10.21M$-10.99M$-16.49M$-17.01M$-15.91M$-16.94M$-19.75M
Low Forecast$-10.21M$-10.21M$-10.21M$-9.42M$-9.42M$-9.42M$-9.42M$-9.42M$-10.21M$-10.21M$-10.21M$-10.99M$-16.49M$-17.01M$-15.91M$-16.94M$-19.75M
Surprise %---------------1.35%0.85%

Akili's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. AKLI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Akili SG&A Forecast

Dec 26Oct 26Jul 26Mar 26Dec 25Oct 25Jul 25Mar 25Dec 24Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Dec 22
# Analysts11111111111111111
SG&A---------------$13.01M$14.45M
Avg Forecast$148.12M$135.38M$122.52M$109.85M$96.57M$90.53M$78.46M$72.43M$60.36M$60.36M$54.32M$48.29M$48.29M$19.50M$14.35M$11.54M$3.16M
High Forecast$148.12M$135.38M$122.52M$109.85M$96.57M$90.53M$78.46M$72.43M$60.36M$60.36M$54.32M$48.29M$48.29M$19.50M$14.35M$11.54M$3.16M
Low Forecast$148.12M$135.38M$122.52M$109.85M$96.57M$90.53M$78.46M$72.43M$60.36M$60.36M$54.32M$48.29M$48.29M$19.50M$14.35M$11.54M$3.16M
Surprise %---------------1.13%4.57%

Akili's average Quarter SG&A projection for Jul 23 is $14.35M, based on 1 Wall Street analysts, with a range of $14.35M to $14.35M. The forecast indicates a 10.32% rise compared to AKLI last annual SG&A of $13.01M (Mar 23).

Akili EPS Forecast

Dec 26Oct 26Jul 26Mar 26Dec 25Oct 25Jul 25Mar 25Dec 24Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Dec 22
# Analysts11111111111111111
EPS---------------$-0.29$-0.22
Avg Forecast$-0.13$-0.13$-0.13$-0.12$-0.12$-0.12$-0.12$-0.12$-0.13$-0.13$-0.13$-0.14$-0.21$-0.22$-0.20$-0.22$-0.25
High Forecast$-0.13$-0.13$-0.13$-0.12$-0.12$-0.12$-0.12$-0.12$-0.13$-0.13$-0.13$-0.14$-0.21$-0.22$-0.20$-0.22$-0.25
Low Forecast$-0.13$-0.13$-0.13$-0.12$-0.12$-0.12$-0.12$-0.12$-0.13$-0.13$-0.13$-0.14$-0.21$-0.22$-0.20$-0.22$-0.25
Surprise %---------------1.34%0.87%

According to undefined Wall Street analysts, Akili's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to AKLI previous annual EPS of $NaN (undefined).

Akili Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AKLIAkili--655.81%Buy
HCATHealth Catalyst--281.85%Buy
FORAForian--115.31%Buy
AUGXAugmedix--13.62%Hold
HQYHealthEquity---7.31%Buy
HSTMHealthStream---8.86%Buy

AKLI Forecast FAQ

Is Akili a good buy?

Yes, according to 2 Wall Street analysts, Akili (AKLI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of AKLI's total ratings.

What is AKLI's price target?

Akili (AKLI) average price target is $3.25 with a range of $2 to $4.5, implying a 652.31% from its last price of $0.432. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Akili stock go up soon?

According to Wall Street analysts' prediction for AKLI stock, the company can go up by 652.31% (from the last price of $0.432 to the average price target of $3.25), up by 941.67% based on the highest stock price target, and up by 362.96% based on the lowest stock price target.

Can Akili stock reach $1?

AKLI's average twelve months analyst stock price target of $3.25 supports the claim that Akili can reach $1 in the near future.

What are Akili's analysts' financial forecasts?

Akili's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $5.6M (high $5.6M, low $5.6M), average EBITDA is $-5.6M (high $-5.6M, low $-5.6M), average net income is $-37.693M (high $-37.693M, low $-37.693M), average SG&A $338M (high $338M, low $338M), and average EPS is $-0.48 (high $-0.48, low $-0.48). AKLI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $8.55M (high $8.55M, low $8.55M), average EBITDA is $-8.547M (high $-8.547M, low $-8.547M), average net income is $-40.049M (high $-40.049M, low $-40.049M), average SG&A $515.87M (high $515.87M, low $515.87M), and average EPS is $-0.51 (high $-0.51, low $-0.51).

Did the AKLI's actual financial results beat the analysts' financial forecasts?

Based on Akili's last annual report (Dec 2022), the company's revenue was $323K, beating the average analysts forecast of $52.34K by 517.08%. Apple's EBITDA was $-90.677M, beating the average prediction of $-52.343K by 173136.15%. The company's net income was $-7.964M, missing the average estimation of $-19.75M by -59.68%. Apple's SG&A was $61.7M, beating the average forecast of $3.16M by 1853.03%. Lastly, the company's EPS was $-0.1, missing the average prediction of $-0.252 by -60.24%. In terms of the last quarterly report (Mar 2023), Akili's revenue was $113K, missing the average analysts' forecast of $191.17K by -40.89%. The company's EBITDA was $-17.999M, beating the average prediction of $-191K by 9315.33%. Akili's net income was $-22.925M, beating the average estimation of $-16.942M by 35.31%. The company's SG&A was $13.01M, beating the average forecast of $11.54M by 12.76%. Lastly, the company's EPS was $-0.29, beating the average prediction of $-0.216 by 34.41%